At Mogrify, you’ll be joining a passionate and innovative team of world experts whose mission is to transform the future development of cell therapies, as well as pioneer an entirely new class of in vivo reprogramming therapies using our proprietary suite of platforms to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). Working in a highly dynamic and collaborative environment, you will help to develop scalable ex vivo cell therapies and in vivo reprogramming therapies for immuno-oncology, ophthalmology and other diseases with a high unmet clinical need, making a difference to your colleagues, collaborators and to the patients we serve.
We believe that success is a journey undertaken by aligned individuals who respect and enjoy each other—an ethos, that since our inception has enabled Mogrify to redefine what is possible for a newly formed biotech. To date, we have raised over $37 million USD funding, established a team with unparalleled track records and received recognition from industry peers for our innovation and potential to be transformative in the discovery and development of new medicines.No profile information